- ShockGuard™ technology with DecisionTx™ programming designed to reduce inappropriate therapy and minimise the need for programming adjustments at implant
- Streamlined header connectors (IS4-LLLL/DF4-LLHH) reduce pocket bulk
- QHR™ battery provides greater capacity for enhanced longevity and improved charge time performance
- Antitachycardia pacing (ATP) while charging and prior to charging in the VF zone further extends the programming options for converting tachyarrhythmias before or during charge
- The % BiV-Pacing alert notifies patients and their clinics when percent biventricular pacing is less than the programmed threshold
- BiVCap™, LVCap™, RVCap™ and ACap™ Confirm features promote patient safety by automatically ensuring capture of the myocardium in response to pacing stimuli in the left ventricle, right ventricle and right atrium
- DeFT Response™ technology tools provide more clinically proven, noninvasive options for managing high DFTs
- QuickOpt™ timing cycle optimisation provides quick and effective optimisation for more patients at the push of a button
QHR is a trademark of Greatbatch Medical
1Singh, J.P. et al. Left ventricular lead position and clinical outcome in the Multicenter Automatic Defibrillator Implantation Trial Cardiac Resynchronization Therapy (MADIT-CRT) trial. Circulation 2011 Mar 22;123(11):1159-66.
2Merchant, F.M. et al. Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes.
Heart Rhythm. 2010 May;7(5):639-44.
3Thibault, B. et al. Electrode selection to avoid phrenic stimulation with a quadripolar left heart lead.
Heart Rhythm. 2011;8(5):S68 (Abs. AB30-3)
4Tomassoni, G. et al. Post operative performance of a novel left ventricular quadripolar electrode lead.
Heart Rhythm. 2011;8(5):S119 (Abs. PO1-43)
5Forleo, G.B. et al. Left ventricular pacing with a new quadripolar transvenous lead for CRT: early results of a prospective comparison with conventional implant outcomes. Heart Rhythm. 2011 Jan;8(1):31-7.